Cailing Chen
Cailing Chen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Wei Li
Research and Development Department Jinqiao Biotech co., Ltd. Huaian Jiangsu China
2 shared publications - Fang He
College of Food Science and Technology, Hunan Agricultural University, Changsha 410128, China
1 shared publication - Hengxian Qu
College of Food Science and Technology Yangzhou University Yangzhou China
1 shared publication - Hongbo Zhou
School of Minerals Processing and Bioengineering, Central South University, Changsha 410083, China
1 shared publication Huilan Ye
Department of Basic Research, Global Research and Development Center, Ausnutria Dairy (China) Co., Ltd., Changsha, China
1 shared publicationJiaqi Wang
Department of Basic Research, Global Research and Development Center, Ausnutria Dairy (China) Co., Ltd., Changsha, China
1 shared publication
Latest Publications
- Open Access
- 31 May 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (6) , 1240
Evolutionary Screening of Lacticaseibacillus rhamnosus MP108 for Freeze–Thaw Tolerance
Freeze-drying is the most commonly used method for preserving probiotics. The freeze tolerance of probiotics has a significant impact on both their survival rate and the expression of their functional properties. To enhance the freeze tolerance of probiotics, this study established an adaptive evolution protocol combining cold stress with repeated freeze–thaw cycles to screen for freeze–thaw-tolerant evolved strains of Lacticaseibacillus rhamnosus MP108. The safety, metabolic, and functional characteristics of these strains were then evaluated. The results showed that the combination of the 8 h cold stress treatment at 4 °C and nine cycles of freezing and thawing at −20 °C effectively enhanced the strain’s freeze tolerance, and the evolved strain L134 was successfully screened through adaptive evolution. Its freeze-dried survival rate and storage survival rate after 6 months of storage were both significantly higher than those of the parental strain (p < 0.05). Furthermore, it exhibited good passage stability. At the same time, the safety and acid-producing characteristics of L134 did not show significant changes compared to the parental strain. Furthermore, its tolerance to simulated gastric fluid, antibacterial activity, and antioxidant capacity were significantly enhanced (p < 0.05). In particular, compared to MP108, L134 exhibited significantly increased hydroxyl radical scavenging capacity as well as higher activities of the antioxidant enzymes SOD and CAT (p < 0.05); the improvement in its freeze tolerance may be related to this enhanced antioxidant capacity.
- 31 May 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (6) , 1240
Open AccessEvolutionary Screening of Lacticaseibacillus rhamnosus MP108 for Freeze–Thaw Tolerance
Freeze-drying is the most commonly used method for preserving probiotics. The freeze tolerance of probiotics has a significant impact on both their survival rate and the expression of their functional properties. To enhance the freeze tolerance of probiotics, this study established an adaptive evolution protocol combining cold stress with repeated freeze–thaw cycles to screen for freeze–thaw-tolerant evolved strains of Lacticaseibacillus rhamnosus MP108. The safety, metabolic, and functional characteristics of these strains were then evaluated. The results showed that the combination of the 8 h cold stress treatment at 4 °C and nine cycles of freezing and thawing at −20 °C effectively enhanced the strain’s freeze tolerance, and the evolved strain L134 was successfully screened through adaptive evolution. Its freeze-dried survival rate and storage survival rate after 6 months of storage were both significantly higher than those of the parental strain (p < 0.05). Furthermore, it exhibited good passage stability. At the same time, the safety and acid-producing characteristics of L134 did not show significant changes compared to the parental strain. Furthermore, its tolerance to simulated gastric fluid, antibacterial activity, and antioxidant capacity were significantly enhanced (p < 0.05). In particular, compared to MP108, L134 exhibited significantly increased hydroxyl radical scavenging capacity as well as higher activities of the antioxidant enzymes SOD and CAT (p < 0.05); the improvement in its freeze tolerance may be related to this enhanced antioxidant capacity.
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Food Science
- Vol. 2026 (1)
Effects and Mechanisms of Lactobacillus rhamnosus MP108 Probiotic Intervention During Pregnancy on Offspring Neurodevelopment
The early stages of life constitute a crucial period for neurodevelopment, during which maternal gut microbiota dysbiosis can impact offspring neurodevelopment via the microbiota–gut–brain axis. This study aimed to examine the ameliorative effects of administering the probiotic Lactobacillus rhamnosus MP108 during pregnancy on neurodevelopmental impairments in offspring induced by a maternal high‐fat diet. The findings indicated that the MP108 intervention significantly ameliorated cognitive and behavioral abnormalities in offspring resulting from maternal obesity. Additionally, it restructured the gut microbiota composition in both mothers and offspring, enhancing the prevalence of beneficial bacteria such as Blautia and Alloprevotella. Metabolomic analysis further revealed that MP108 reduced intestinal levels of L‐homocystine and methionine while increasing those of L‐(+)‐arginine, L‐(+)‐citrulline, and L‐tyrosine. Furthermore, MP108 markedly attenuated the aberrant expression of neuroinflammatory and myelin formation–related genes in the hippocampal region of offspring, including cyclooxygenase‐2 (Cox2), nuclear factor kappa‐B (NF‐κB), and myelin basic protein (MBP), thereby restoring their expression levels to normative ranges. This study represents the first evidence that maternal intervention with MP108 during gestation influences gut microbiota composition and metabolite profiles, subsequently reducing neuroinflammation and facilitating neural development. This mechanism effectively alleviates the detrimental effects of a maternal high‐fat diet on the neural development of offspring, thereby providing empirical support for the potential application of MP108 in the prevention and amelioration of neurodevelopmental disorders.
- 1 January 2026
- Published by Wiley in International Journal of Food Science
- Vol. 2026 (1)
Open AccessEffects and Mechanisms of Lactobacillus rhamnosus MP108 Probiotic Intervention During Pregnancy on Offspring Neurodevelopment
The early stages of life constitute a crucial period for neurodevelopment, during which maternal gut microbiota dysbiosis can impact offspring neurodevelopment via the microbiota–gut–brain axis. This study aimed to examine the ameliorative effects of administering the probiotic Lactobacillus rhamnosus MP108 during pregnancy on neurodevelopmental impairments in offspring induced by a maternal high‐fat diet. The findings indicated that the MP108 intervention significantly ameliorated cognitive and behavioral abnormalities in offspring resulting from maternal obesity. Additionally, it restructured the gut microbiota composition in both mothers and offspring, enhancing the prevalence of beneficial bacteria such as Blautia and Alloprevotella. Metabolomic analysis further revealed that MP108 reduced intestinal levels of L‐homocystine and methionine while increasing those of L‐(+)‐arginine, L‐(+)‐citrulline, and L‐tyrosine. Furthermore, MP108 markedly attenuated the aberrant expression of neuroinflammatory and myelin formation–related genes in the hippocampal region of offspring, including cyclooxygenase‐2 (Cox2), nuclear factor kappa‐B (NF‐κB), and myelin basic protein (MBP), thereby restoring their expression levels to normative ranges. This study represents the first evidence that maternal intervention with MP108 during gestation influences gut microbiota composition and metabolite profiles, subsequently reducing neuroinflammation and facilitating neural development. This mechanism effectively alleviates the detrimental effects of a maternal high‐fat diet on the neural development of offspring, thereby providing empirical support for the potential application of MP108 in the prevention and amelioration of neurodevelopmental disorders.
- Open Access
Antidepressant Effects of Bifidobacterium animalis CP-9 in LPS-Induced Depressive Mice
Depression is a common mood disorder, and growing evidence has revealed the critical role of gut microbiota in its onset and progression. The gut–brain axis, which connects the central nervous system and intestinal microecology, offers new strategies for depression intervention. In this study, an acute depression model was established in mice using lipopolysaccharide (LPS), and the potential antidepressant effects and mechanisms of Bifidobacterium animalis CP-9 were investigated. The results indicated that CP-9 may exert antidepressant effects through multiple pathways, including modulation of peripheral and central inflammatory responses, restoration of gut microbiota balance, enhancement of short-chain fatty acid (SCFA) production, and regulation of neurotransmitter metabolism such as γ-aminobutyric acid (GABA) and 5-hydroxytryptamine (5-HT). Notably, intervention with CP-9 at a dose of 108 CFU/mL significantly alleviated depressive-like behaviors in mice, suggesting its promising potential in the prevention and treatment of mood disorders.
Open AccessAntidepressant Effects of Bifidobacterium animalis CP-9 in LPS-Induced Depressive Mice
Depression is a common mood disorder, and growing evidence has revealed the critical role of gut microbiota in its onset and progression. The gut–brain axis, which connects the central nervous system and intestinal microecology, offers new strategies for depression intervention. In this study, an acute depression model was established in mice using lipopolysaccharide (LPS), and the potential antidepressant effects and mechanisms of Bifidobacterium animalis CP-9 were investigated. The results indicated that CP-9 may exert antidepressant effects through multiple pathways, including modulation of peripheral and central inflammatory responses, restoration of gut microbiota balance, enhancement of short-chain fatty acid (SCFA) production, and regulation of neurotransmitter metabolism such as γ-aminobutyric acid (GABA) and 5-hydroxytryptamine (5-HT). Notably, intervention with CP-9 at a dose of 108 CFU/mL significantly alleviated depressive-like behaviors in mice, suggesting its promising potential in the prevention and treatment of mood disorders.